Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.
17/5 17:02
Key PointsCEO Paul LaViolette acquired 15,000 shares for a total cost of ~$295,000 on May 11, 2026....
17/5 17:02
Key PointsCEO Paul LaViolette acquired 15,000 shares for a total cost of ~$295,000 on May 11, 2026....